Journalartikel

Jahr der Veröffentlichung: 2017

Seiten: 480-485

Zeitschrift: Nervenarzt

Bandnummer: 88

Heftnummer: 5

ISSN: 0028-2804

eISSN: 1433-0407

DOI Link: https://doi.org/10.1007/s00115-017-0301-7

Verlag: Springer

Abstract: 

A testosterone-lowering medication is relatively commonly used as a form of treatment for sexual offenders with severe paraphilic disorders in German forensic psychiatric hospitals; however, a double-blind, controlled and randomized study, which investigates the efficacy of this medication, is still lacking.

This article describes the process from the planning to the rejection of a clinical trial over the period from 2009 to 2015.

Despite the careful planning with an interdisciplinary team and giving special consideration to the complex legal situation, the Federal Institute for Drugs and Medical Devices (BfArM) rejected the proposed trial in a brief formal letter with reference to the German Drug Law (A A 40 para. 1 p. 3 nr. 4 AMG). The ethics committee of the Hamburg Medical Association considered that clinical research is basically not possible with patients detained in a forensic psychiatric hospital.

In the opinion of the authors, the described facts illustrate how legal regulations that should protect vulnerable groups in medical research, in a specific case can lead to the fact that a therapy form relevant to the corresponding patient group cannot be scientifically investigated.

Harvard-Zitierstil: Briken, P., Mueller, J., Berner, W., Boedeker, R., Vollmann, J., Kasperk, C., et al. (2017) Failure of a study in forensic psychiatric hospitals. Clinical trial to investigate the additive effect of triptorelin on the efficacy of psychotherapy, Nervenarzt, 88(5), pp. 480-485. https://doi.org/10.1007/s00115-017-0301-7

APA-Zitierstil: Briken, P., Mueller, J., Berner, W., Boedeker, R., Vollmann, J., Kasperk, C., & Koller, M. (2017). Failure of a study in forensic psychiatric hospitals. Clinical trial to investigate the additive effect of triptorelin on the efficacy of psychotherapy. Nervenarzt. 88(5), 480-485. https://doi.org/10.1007/s00115-017-0301-7